Archive Newsletter

  1. 06.02.26 -- Why the Right Manufacturing Partner Is About More Than Capacity 6/2/2026
    06/02/26 Cell & Gene Newsletter
  2. 06.01.26 -- Cut Variability, Raise Titers, And Scale With Confidence 6/1/2026

    06/01/26 Cell & Gene Newsletter

  3. 06.01.26 -- CGT Manufacturing Shifts From Capacity To Strategy 6/1/2026
    06/01/26 Cell & Gene Newsletter
  4. 05.29.26 -- Securing Your Advanced Therapy Pipeline 5/29/2026
    05/29/26 Cell & Gene Newsletter
  5. 05.29.26 -- Materials Matter: Reframing Raw Material Strategy In Cell And Gene Therapy Development 5/29/2026
    05/29/26
  6. 05.28.26 -- Accelerate Your Assay And Imaging Data With These New Tools 5/28/2026
    05/28/26 Cell & Gene Newsletter
  7. 05.28.26 -- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook 5/28/2026
    05/28/26 Cell & Gene Newsletter
  8. 05.27.26 -- Smarter Processing For Workflows From Discovery To Commercial Scale 5/27/2026
    05/27/26 Cell & Gene Newsletter
  9. 05.27.26 -- Rethinking Sterile Welding In Bioprocessing 5/27/2026

    05/27/26 Cell & Gene Newsletter

  10. 05.27.26 -- Bridging Analytical Gaps To Ensure CGT Material Quality 5/27/2026
    05/27/26 Cell & Gene Newsletter